Robert A. Kyle

Research interests

Publications

• Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

  New England Journal of Medicine · 2018 · 10.1056/nejmoa1709974

• Multiple myeloma

  Nature Reviews Disease Primers · 2017 · https://doi.org/10.1038/nrdp.2017.46

• Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

  Blood · 2016 · https://doi.org/10.1182/blood-2016-01-631200

• International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

  The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30206-6

• Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

  Journal of the American College of Cardiology · 2016 · 10.1016/j.jacc.2016.06.033

• International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

  The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70442-5

• Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

  Leukemia · 2013 · https://doi.org/10.1038/leu.2013.313

• Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

  Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.38.5724

• Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

  Blood · 2011 · 10.1182/blood-2010-10-299487

• Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

  Leukemia · 2011 · 10.1038/leu.2011.196

• Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

  Leukemia · 2010 · 10.1038/leu.2010.60

• Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

  Mayo Clinic Proceedings · 2009 · 10.4065/mcp.2009.0603

• Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

  Blood · 2009 · 10.1182/blood-2008-12-194241

• Increased Prevalence and Mortality in Undiagnosed Celiac Disease

  Gastroenterology · 2009 · 10.1053/j.gastro.2009.03.059

• International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

  Leukemia · 2008 · 10.1038/leu.2008.307

• Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

  Leukemia · 2008 · 10.1038/leu.2008.291

• Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

  New England Journal of Medicine · 2007 · 10.1056/nejmoa070389

• Improved survival in multiple myeloma and the impact of novel therapies

  Blood · 2007 · 10.1182/blood-2007-10-116129

• Prevalence of Monoclonal Gammopathy of Undetermined Significance

  New England Journal of Medicine · 2006 · 10.1056/nejmoa054494

• International uniform response criteria for multiple myeloma

  Leukemia · 2006 · 10.1038/sj.leu.2404284

• Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

  Blood · 2005 · 10.1182/blood-2005-03-1038

• Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

  Blood · 2005 · 10.1182/blood-2005-07-2817

• International Staging System for Multiple Myeloma

  Journal of Clinical Oncology · 2005 · 10.1200/jco.2005.04.242

• Multiple Myeloma

  New England Journal of Medicine · 2004 · 10.1056/nejmra041875

• Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

  Journal of Clinical Oncology · 2004 · 10.1200/jco.2004.03.029

• POEMS syndrome: definitions and long-term outcome

  Blood · 2003 · 10.1182/blood-2002-07-2299

• Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

  Mayo Clinic Proceedings · 2003 · 10.4065/78.1.21

• A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

  New England Journal of Medicine · 2002 · 10.1056/nejmoa01133202

Current projects

No projects listed.